NEW PAPER! In this month's The Bulletin of the World Health Organization, a group of us from UK Academics and Professionals to End TB have a paper calling for a platform trial to evaluate new drug resistant TB (DRTB) treatment regimens ncbi.nlm.nih.gov/pmc/articles/P… Here is a short thread outlining some of our key arguments [1/n]

Really happy about seeing this chart of mine in a printed book. Edward Tufte included my chart on life expectancy vs health expenditure in his latest book!

24th September - please join us online for Devan Mehrotra's seminar on 'Covariate adjustment using treatment-blinded covariate selection within randomized clinical trials', hosted by Data & Statistical Science for Health, LSHTM. lshtm.ac.uk/newsevents/eve…

People with drug-resistant #tuberculosis deserve even shorter and more tolerable treatment regimens without the fear of growing resistance to new drugs. Read Tom Yates thread below of arguments UK Academics and Professionals to End TB have made for a platform trial for results this decade, not the next ⤵️

Just wondering what the criteria are for ‘leading clinician’ and ‘top doctor’ if anyone can let me know ta

How to escape the ‘heroin hustle’: the project helping South African addicts theguardian.com/global-develop…